Pay in 4 interest-free payments of $5.18 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
Lillys triple agonist, retatrutide, delivered weight loss of up to an average of 71.2 lbs along with substantial relief from osteoarthritis pain in first successful Phase 3 trial. Press release
Receptor Grade IGF-1 LR3 Studies and Research Data Investigations on Cellular Proliferation Research suggests that IGF-1 LR3 may encourage cellular division and maturation across multiple tissue types, including those of muscle, bone, and liver
You receive a tracking number to track your order
Food Chem
Clinical trials have shown greater weight loss with Tirzepatide, with some studies reaching up to 22.5% weight loss on average
By staying engaged and informed, you can confidently navigate your wellness journey and continue to make choices that align with your goals
US$ 20.36
US$ 24.88
US$ 23.15
US$ 28.50
US$ 21.16
US$ 29.09
